SARomics Biostructures provides premium protein crystallization, protein crystallography and structure-based drug design outsourcing services. Our strategic location in close vicinity to the MAX-lab synchrotron radiation facility in Lund, Sweden, provides us with instant access to beamlines, eliminating the need for crystal transportation to remote synchrotrons and allowing us to offer to our customers quick services at highly competitive prices.
Please view the details of our structural biology services technology platform or contact us directly for the discussion of your project.
Meet SARomics Biostructures at Bio-Europe, November 2-4 in Munich.
SARomics Biostructures collaborates with Prof. G Schneider (ETH Zürich) in a study in which automated molecular de novo design led to the discovery of an innovative inhibitor of death-associated protein kinase 3 (DAPK3)! Read more…
SARomics Biostructures joins the Merozyne project aiming to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy. Press release…
Meet SARomics Biostructures at BioStruct-X Industrial Workshop, 15-17 of June, Hamburg
Meet SARomics Biostructures at Drug Discover Chemistry, San Diego, USA.
New 2015 company presentation is released and can be viewed on SlideShare.
SARomics Biostructures opens U.S. sales office! Pressrelease…